FDA Pulls Emergency Use Authorization for Antimalarial Drugs
FDA Pulls Emergency Use Authorization for Antimalarial Drugs
Hydroxychloroquine and chloroquine, once thought to be promising COVID-19 treatments, come with serious heart risks.
Hydroxychloroquine and chloroquine, once thought to be promising COVID-19 treatments, come with serious heart risks.
chloroquine
Disputed Hydroxychloroquine Study Brings Scrutiny to Surgisphere
Catherine Offord | May 30, 2020 | 9 min read
Scientists have raised questions about the dataset published in The Lancet last week that triggered the suspension of clinical trials around the world—and about Surgisphere Corporation, the company behind the study.
WHO Halts Hydroxychloroquine Testing Over Safety Concerns
Catherine Offord | May 27, 2020 | 4 min read
A paper published in The Lancet reported that hospitalized COVID-19 patients taking the drug had a higher risk of death, although some researchers have raised questions about the data.
Journal Publisher Concerned over Hydroxychloroquine Study
Kerry Grens | Apr 9, 2020 | 2 min read
The report by Didier Raoult and colleagues that examined the use of the anti-malarial drug in a small number of COVID-19 patients receives criticism from the very society that published it.
Chloroquine for COVID-19: Cutting Through the Hype
Chris Baraniuk | Mar 20, 2020 | 4 min read
President Donald Trump has touted the drug as a treatment but scientists still don’t know for sure that it is effective in patients. A number of clinical trials aim to find out.